Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 230 followers
Latest posts
Last updated about 10 hours ago
New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
about 10 hours ago
A new U.S. policy that recommends offering hepatitis B vaccine at birth...
Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims
about 10 hours ago
WASHINGTON — The Supreme Court seemed divided Monday over whether to block...
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
about 10 hours ago
The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in...
Dems says RFK Jr. has a pattern of failing to answer their questions
about 11 hours ago
WASHINGTON — Last week, Sen. Ben Ray Luján (D-N.M.) asked health secretary...
Trump administration warns against using federal dollars on fentanyl test strips
about 12 hours ago
The Trump administration is doubling down on its opposition to harm reduction...
STAT+: An insider reveals the real goals of prior authorization
about 16 hours ago
This is the online version of STAT’s weekly email newsletter Health Care...
Astellas retries XLMTM gene therapy after deaths
about 17 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more
about 17 hours ago
Good morning, everyone, and welcome to another working week. We hope the...
What’s the true risk for eating disorders with GLP-1s?
about 18 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
about 19 hours ago
Intellia Therapeutics said Monday that a single dose of its gene editing...
STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
about 19 hours ago
A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve...
STAT+: Veradermics’ hair loss drug succeeds in late-stage trial
about 19 hours ago
An oral medicine for hair loss successfully spurred hair growth in a...